DRUG·10919W405·US·equity·Healthcare - Biotechnology-13D/G
DRUG (BRIGHT MINDS BIOSCIENCES INC) is held by 53 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($93.5M), BlackRock, Inc. ($45.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($36.2M). Net institutional sentiment: Bullish.
See how DRUG's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer